Medical College of Wisconsin
CTSIResearch InformaticsREDCap

Real-world use of tisagenlecleucel in children and young adults with relapsed or refractory B-cell lymphomas. Blood Adv 2024 Aug 13;8(15):4164-4168

Date

06/25/2024

Pubmed ID

38916857

Pubmed Central ID

PMC11334869

DOI

10.1182/bloodadvances.2024012928

Scopus ID

2-s2.0-85201500415 (requires institutional sign-in at Scopus site)   4 Citations

Author List

Bender JD, Damodharan S, Capitini CM, Moskop A, Toner K, Vatsayan A, Talano JA, Baggott C, Schiff D, Katsanis E, Modi AJ, Quigg TC, Raikar SS, Schultz LM, Pommert L

Authors

Amy Moskop MD Associate Professor in the Pediatrics department at Medical College of Wisconsin
Julie-An M. Talano MD Professor in the Pediatrics department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Adolescent
Adult
Child
Child, Preschool
Female
Humans
Immunotherapy, Adoptive
Lymphoma, B-Cell
Male
Receptors, Antigen, T-Cell
Recurrence
Treatment Outcome
Young Adult